| pubmed-article:10799248 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:10799248 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:10799248 | lifeskim:mentions | umls-concept:C0005682 | lld:lifeskim |
| pubmed-article:10799248 | lifeskim:mentions | umls-concept:C0027096 | lld:lifeskim |
| pubmed-article:10799248 | lifeskim:mentions | umls-concept:C0597298 | lld:lifeskim |
| pubmed-article:10799248 | lifeskim:mentions | umls-concept:C0184511 | lld:lifeskim |
| pubmed-article:10799248 | lifeskim:mentions | umls-concept:C0332281 | lld:lifeskim |
| pubmed-article:10799248 | lifeskim:mentions | umls-concept:C0017262 | lld:lifeskim |
| pubmed-article:10799248 | lifeskim:mentions | umls-concept:C0205349 | lld:lifeskim |
| pubmed-article:10799248 | lifeskim:mentions | umls-concept:C2911684 | lld:lifeskim |
| pubmed-article:10799248 | lifeskim:mentions | umls-concept:C0058623 | lld:lifeskim |
| pubmed-article:10799248 | lifeskim:mentions | umls-concept:C0185117 | lld:lifeskim |
| pubmed-article:10799248 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:10799248 | pubmed:dateCreated | 2000-6-27 | lld:pubmed |
| pubmed-article:10799248 | pubmed:abstractText | Tadenan is a plant extract from Pygeum africanum used in the treatment of benign prostatic hyperplasia, to protect the bladder from contractile dysfunction induced by partial bladder outlet obstruction (BOO). The aim of the present study was to determine whether the Tadenan-induced return of detrusor contractility affects the expression of myosin isoforms, which differ at the C-terminal (SM1 and SM2) and the N-terminal regions (SM-A and SM-B). | lld:pubmed |
| pubmed-article:10799248 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10799248 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10799248 | pubmed:language | eng | lld:pubmed |
| pubmed-article:10799248 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10799248 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:10799248 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10799248 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10799248 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10799248 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10799248 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10799248 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:10799248 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:10799248 | pubmed:issn | 0022-5347 | lld:pubmed |
| pubmed-article:10799248 | pubmed:author | pubmed-author:LevinR MRM | lld:pubmed |
| pubmed-article:10799248 | pubmed:author | pubmed-author:WeinA JAJ | lld:pubmed |
| pubmed-article:10799248 | pubmed:author | pubmed-author:ChackoSS | lld:pubmed |
| pubmed-article:10799248 | pubmed:author | pubmed-author:HoranPP | lld:pubmed |
| pubmed-article:10799248 | pubmed:author | pubmed-author:GomesC MCM | lld:pubmed |
| pubmed-article:10799248 | pubmed:author | pubmed-author:DisantoM EME | lld:pubmed |
| pubmed-article:10799248 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:10799248 | pubmed:volume | 163 | lld:pubmed |
| pubmed-article:10799248 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:10799248 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:10799248 | pubmed:pagination | 2008-13 | lld:pubmed |
| pubmed-article:10799248 | pubmed:dateRevised | 2009-11-19 | lld:pubmed |
| pubmed-article:10799248 | pubmed:meshHeading | pubmed-meshheading:10799248... | lld:pubmed |
| pubmed-article:10799248 | pubmed:meshHeading | pubmed-meshheading:10799248... | lld:pubmed |
| pubmed-article:10799248 | pubmed:meshHeading | pubmed-meshheading:10799248... | lld:pubmed |
| pubmed-article:10799248 | pubmed:meshHeading | pubmed-meshheading:10799248... | lld:pubmed |
| pubmed-article:10799248 | pubmed:meshHeading | pubmed-meshheading:10799248... | lld:pubmed |
| pubmed-article:10799248 | pubmed:meshHeading | pubmed-meshheading:10799248... | lld:pubmed |
| pubmed-article:10799248 | pubmed:meshHeading | pubmed-meshheading:10799248... | lld:pubmed |
| pubmed-article:10799248 | pubmed:meshHeading | pubmed-meshheading:10799248... | lld:pubmed |
| pubmed-article:10799248 | pubmed:meshHeading | pubmed-meshheading:10799248... | lld:pubmed |
| pubmed-article:10799248 | pubmed:meshHeading | pubmed-meshheading:10799248... | lld:pubmed |
| pubmed-article:10799248 | pubmed:meshHeading | pubmed-meshheading:10799248... | lld:pubmed |
| pubmed-article:10799248 | pubmed:meshHeading | pubmed-meshheading:10799248... | lld:pubmed |
| pubmed-article:10799248 | pubmed:year | 2000 | lld:pubmed |
| pubmed-article:10799248 | pubmed:articleTitle | Improved contractility of obstructed bladders after Tadenan treatment is associated with reversal of altered myosin isoform expression. | lld:pubmed |
| pubmed-article:10799248 | pubmed:affiliation | Department of Pathobiology and Division of Urology, University of Pennsylvania, Philadelphia, Pennsylvania, USA. | lld:pubmed |
| pubmed-article:10799248 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:10799248 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:10799248 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
